Category - Part 4
Side Effects With Inhaled Corticosteroids: Systematic Review
The authors also showed that immediately after inhalation of 200 ^g of FP, there were significant amounts of FP in the esophagus (3.3 ^g). Even after 30 min, FP remained detectable and the amount of drug recovered was affected by whether the patient was prone or remained upright (0.67 ^g if the patient laid down immediately or 0.11 ^g if they remained standing). This study implies that if asthmatic patients do not go to sleep immediately after FP inhalation, the remaining FP in the esophagus decreases rapidly, thereby decreasing the risk of esophageal candidiasis. review
In addition, by changing the FP inhalation times to before breakfast and dinner, the remaining FP in the esophagus would be removed by the passage of food and would not remain in the esophagus. Thus, physicians need to be aware of the possibility of esophageal candidiasis with FP therapy and advise patients on how to potentially minimize their risk for this side effect.
Continue reading this post…
Side Effects With Inhaled Corticosteroids: Local Side Effects of ICS Therapy
A systematic review compared the dose response for oral candidiasis for FP with the dose response for preventing an exacerbation. The authors calculated the number of patients that needed to be treated to prevent withdrawal of therapy due to worsening of asthma symptoms vs the risk of oral candidiasis. In this analysis, the number of patients who avoided asthma exacerbation by taking FP increased with increasing daily doses of FP, although the dose-response curve was relatively flat, with little benefit in efficacy between FP at 500 ^g and 1,000 ^g. However, as the dose of FP increased, so did the risk of oral candidiasis. At a dose of 100 ^g, the difference between the number of additional patients that would need to be treated to avoid a loss of efficacy vs the number of patients that would need to be treated in order to see an additional case of oral candidiasis was 87 patients (Fig 1). In comparison, at an FP dose of 1,000 ^g, this difference had fallen to 21 patients, a narrow margin of tolerability (Fig 1). Thus, when increasing the dose of FP, the risk of oral candidiasis will increase much faster than the risk of an exacerbation will decrease. read
Side Effects With Inhaled Corticosteroids
Inhaled corticosteroids (ICS) are the cornerstone of asthma management and result in improved symptom control and quality of life for many patients. However, as for all medicines, the physician must achieve a balance between the potential benefits for the patient and the risk of side effects. For ICS therapy, the potential side effects may be local in the oropharyngeal cavity, or systemic due to absorption of ICS into the circulation through the lungs and GI tract. Increasing the dose of ICS in order to achieve improvements in asthma symptoms, or prolonged treatment over many years, will expose patients to an increased risk of side effects. http://cheap-asthma-inhalers.com/
Despite the publication of guidelines2’ stressing the importance of ICS, ICS are often underused. The major reason that physicians fail to prescribe ICS appears to be due to disagreement with recommendations, particularly regarding when the balance lies between their benefits and the risk of complications and side effects. In addition, patients’ fears of ICS may lead to a lack of adherence with prescribed therapy, which may expose them to the unnecessary risk of an asthma exacerbation. Although the nature of local side effects with ICS is fairly well described and understood, the impact of these side effects on patient quality of life and adherence to therapy may be underestimated. However, the most common concerns regarding ICS therapy relate to the potential systemic effects, which are often more serious, long term, and can be difficult to detect and treat.”
Persistence of Airway Obstruction and Hyperresponsiveness in Subjects With Asthma Remission: Comment
Medication may influence symptoms and airway responsiveness. It has been shown that prolonged use of inhaled steroids may reduce airway responsiveness and “induce” remission in some subjects. In our study, only two subjects “in remission” previously took inhaled steroids or prednisone, most subjects using a /82-agonist on demand, in some of them in association with a theophylline. Some subjects took no antiasthma medication.
There was no significant correlation between PC20 and duration of asthma or of remission. This suggests that it is not necessarily the duration of asthma that determines the persistence of airflow obstruction or airway hyperresponsiveness. However, in the study of Chan-Yeung33 on occupational asthma to red cedar, the longer the duration of symptoms and the more intense the antigenic contact, the less likely the remission. Subjects who became asymptomatic following withdrawal from the sensitizing agent had at the time of diagnosis a PC20 and an FEVi much higher than those that remained symptomatic, even after cessation of work Link http://birthcontroltab.com. They also had an early diagnostic of occupational asthma and a shorter exposure period to a sensitizing agent.
Continue reading this post…
Persistence of Airway Obstruction and Hyperresponsiveness in Subjects With Asthma Remission: Conclusion
More than 50 percent of subjects with mild increases in airway response to histamine denied symptoms suggestive of asthma. This is similar to what has been reported by Woolcock et al28 showing that 32 percent of adults with airway hyperresponsiveness never had symptoms suggestive of asthma. This suggests that for a similar degree of airway responsiveness, there may be marked differences in perception of asthma symptoms from one subject to another, although why these differences occur is still to be documented.
Different factors may be involved in the reduction of severity of asthma and “virtual” or true remissions. First, “remissions” of asthma were almost exclusively observed in atopic subjects (28 of our 30 subjects), suggesting that they are possibly in relation with environmental changes such as reduced exposure to relevant allergens or a reduction in immunologic response. This is supported by the observation that most of these subjects avoided exposure to antigens to which they were sensitized. Canadian family pharmacy Link Most of our subjects had mild hyperresponsiveness and little variations of expiratory flow rates (mean daily variation <10 percent). It is possible that they did not encounter in their daily activities or avoided sufficiently triggers that could have caused symptoms.
Continue reading this post…
Persistence of Airway Obstruction and Hyperresponsiveness in Subjects With Asthma Remission: Discussion
In our study, asthma remission occurred between ages 11 and 20 years in most subjects but remissions were also observed after the age of 40 years. Remissions in asthmatic children have been well studied but little is known, however, of asthma remissions in adults. Spontaneous remissions of asthma have been reported to occur in 30 to 70 percent of subjects, mainly at adolescence. Martin et al also showed that children who had minor wheezing in childhood and were wheeze free for at least 3 years had normal pulmonary function, although 60 percent of these had an abnormal bronchial response to inhaled histamine more canadian neighbor pharmacy. Our results are in keeping with these observations as we observed the persistence of an increased response to methacholine in 63 percent of “ex-asthmatics.”
Radford et al compared the level of airway responsiveness between former and present asthmatic children. They reported that former asthmatics had persistence of airway hyperresponsiveness over time, compared with currently symptomatic asthmatics, but to a lesser degree. Gerritsen et al showed that 43 percent of 101 adults with asthma in childhood still had asthma symptoms, although the number of subjects with a PD10 histamine <16 mg/ ml went from 101 children to 29 adults. Of the 43 subjects with persistent symptoms, 59 percent had a positive response to histamine, compared with 7 percent of those without symptoms.
Continue reading this post…
Persistence of Airway Obstruction and Hyperresponsiveness in Subjects With Asthma Remission: Respiratory Symptoms
On initial questionnaire, 29 asthmatics “in remission” (15 controls) described occasional respiratory symptoms following either allergen exposure (n=15, 6 controls), viral infections, or exposure to different conditions or stimuli (humidity, cold air, smoke, heavy exercise).
During the 14-day period of PEFR measurement and symptoms recordings, 12 “ex-asthmatics” (one control) had symptoms such as either dyspnea, cough, wheezing, or chest tightness. In four, these followed exposure to an allergen to which they were sensitized. Of these 12 subjects, 6 had a PC20 <8 mg/ ml, 2 between 8 and 20 mg/ml, 3 >20 mg/ml, and one reacted to saline solution. The control subject, whose PC20 was 54.5 mg/ml, had cough and wheezing; these symptoms were related to recent exposure to tree pollens.
Correlation Between Perception of Bronchoconstriction and Airway Responsiveness or Airflow Obstruction
During methacholine inhalation tests, dyspnea and the perception of a fall in FEVi were evaluated according to a modified Borg scale (0 to 10). Canadian health care mall More info In the 20 asthmatics “in remission” with a PC20 <128 mg/ ml, mean Borg score at 20 percent fall in FEVi was 1.63 ±0.40 for dyspnea and 1.78 ±0.30 for perception of bronchoconstriction (controls [n=19]: dyspnea: 1.05 ±0.25, perception of bronchoconstriction: 1.61 ±0.26). Dyspnea and bronchoconstriction were perceived similarly by both groups of subjects. Perception of dyspnea was significantly correlated to the level of airway responsiveness in the control group only (rs=0.546, p=0.045). There was no significant correlation between the perception of either dyspnea or bronchoconstriction and baseline FEVi.
Continue reading this post…